Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02163746 · ClinicalTrials.gov registry record · NA

Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing

A NA study, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02163746: Completed NA study, sponsored by Henry Ford Health System.

NCT02163746 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02163746, a NA study, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.

Primary Outcome

Quality of Life measures will be measured via DLQI and Skindex29 patient surveys.

Interventions

  • PROCEDURE CO2 (carbon dioxide) laser
  • PROCEDURE Surgical Deroofing

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-01-14
Est. Completion 2016-06-07
Phase NA
Henry Ford Health System

234 total trials

What the finished NCT02163746 record still lists

NCT02163746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which CO2 (carbon dioxide) laser is the first listed.

NCT02163746 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02163746 about?

NCT02163746 is a clinical study titled "Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing". This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.

What is the current status of trial NCT02163746?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-01-14. Estimated completion is 2016-06-07.

What interventions are being tested in trial NCT02163746?

The interventions under investigation include: CO2 (carbon dioxide) laser (PROCEDURE), Surgical Deroofing (PROCEDURE).

Who is sponsoring clinical trial NCT02163746?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02163746's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02163746, the US trial registry maintained by the National Library of Medicine. NCT02163746 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.